These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 21858226)

  • 21. Increased long-term immunity to Bacillus anthracis protective antigen in mice immunized with a CIA06B-adjuvanted anthrax vaccine.
    Wui SR; Han JE; Kim YH; Rhie GE; Lee NG
    Arch Pharm Res; 2013 Apr; 36(4):464-71. PubMed ID: 23440578
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A three-dose intramuscular injection schedule of anthrax vaccine adsorbed generates sustained humoral and cellular immune responses to protective antigen and provides long-term protection against inhalation anthrax in rhesus macaques.
    Quinn CP; Sabourin CL; Niemuth NA; Li H; Semenova VA; Rudge TL; Mayfield HJ; Schiffer J; Mittler RS; Ibegbu CC; Wrammert J; Ahmed R; Brys AM; Hunt RE; Levesque D; Estep JE; Barnewall RE; Robinson DM; Plikaytis BD; Marano N;
    Clin Vaccine Immunol; 2012 Nov; 19(11):1730-45. PubMed ID: 22933399
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Defining a novel subset of CD1d-dependent type II natural killer T cells using natural killer cell-associated markers.
    Singh AK; Rhost S; Löfbom L; Cardell SL
    Scand J Immunol; 2019 Sep; 90(3):e12794. PubMed ID: 31141185
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Suppression of collagen-induced arthritis by natural killer T cell activation with OCH, a sphingosine-truncated analog of alpha-galactosylceramide.
    Chiba A; Oki S; Miyamoto K; Hashimoto H; Yamamura T; Miyake S
    Arthritis Rheum; 2004 Jan; 50(1):305-13. PubMed ID: 14730629
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Donor bone marrow type II (non-Valpha14Jalpha18 CD1d-restricted) NKT cells suppress graft-versus-host disease by producing IFN-gamma and IL-4.
    Kim JH; Choi EY; Chung DH
    J Immunol; 2007 Nov; 179(10):6579-87. PubMed ID: 17982047
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential contribution of dendritic cell CD1d to NKT cell-enhanced humoral immunity and CD8+ T cell activation.
    Joshi SK; Lang GA; Devera TS; Johnson AM; Kovats S; Lang ML
    J Leukoc Biol; 2012 May; 91(5):783-90. PubMed ID: 22331103
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A combination of the TLR4 agonist CIA05 and alum promotes the immune responses to Bacillus anthracis protective antigen in mice.
    Wui SR; Kim HK; Han JE; Kim JM; Kim YH; Chun JH; Cho YJ; Lee NG
    Int Immunopharmacol; 2011 Sep; 11(9):1195-204. PubMed ID: 21492746
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A comparison of non-toxin vaccine adjuvants for their ability to enhance the immunogenicity of nasally-administered anthrax recombinant protective antigen.
    Gwinn WM; Johnson BT; Kirwan SM; Sobel AE; Abraham SN; Gunn MD; Staats HF
    Vaccine; 2013 Mar; 31(11):1480-9. PubMed ID: 23352329
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The pro-Th2 cytokine IL-33 directly interacts with invariant NKT and NK cells to induce IFN-gamma production.
    Bourgeois E; Van LP; Samson M; Diem S; Barra A; Roga S; Gombert JM; Schneider E; Dy M; Gourdy P; Girard JP; Herbelin A
    Eur J Immunol; 2009 Apr; 39(4):1046-55. PubMed ID: 19266498
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Both Th1 and Th2 cytokines affect the ability of monoclonal antibodies to protect mice against Cryptococcus neoformans.
    Beenhouwer DO; Shapiro S; Feldmesser M; Casadevall A; Scharff MD
    Infect Immun; 2001 Oct; 69(10):6445-55. PubMed ID: 11553589
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protection against anthrax toxin by vaccination with a DNA plasmid encoding anthrax protective antigen.
    Gu ML; Leppla SH; Klinman DM
    Vaccine; 1999 Jan; 17(4):340-4. PubMed ID: 9987172
    [TBL] [Abstract][Full Text] [Related]  

  • 32. OCH-mediated shift of Th1 and Th2 cytokines by NKT cells in mice with aplastic anemia.
    Qiao X; Xie X; Shi W; Tang J; Shao Y; Li F
    Med Oncol; 2015 Mar; 32(3):67. PubMed ID: 25691295
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anthrax Vaccine Precipitated Induces Edema Toxin-Neutralizing, Edema Factor-Specific Antibodies in Human Recipients.
    Dumas EK; Gross T; Larabee J; Pate L; Cuthbertson H; Charlton S; Hallis B; Engler RJM; Collins LC; Spooner CE; Chen H; Ballard J; James JA; Farris AD
    Clin Vaccine Immunol; 2017 Nov; 24(11):. PubMed ID: 28877928
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CD40L-null NKT cells provide B cell help for specific antibody responses.
    Shah HB; Joshi SK; Lang ML
    Vaccine; 2011 Nov; 29(49):9132-6. PubMed ID: 21959330
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Search for correlates of protective immunity conferred by anthrax vaccine.
    Reuveny S; White MD; Adar YY; Kafri Y; Altboum Z; Gozes Y; Kobiler D; Shafferman A; Velan B
    Infect Immun; 2001 May; 69(5):2888-93. PubMed ID: 11292703
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of Th1/Th2 cytokine polarity induced by invariant NKT cells on the incidence of pregnancy loss in mice.
    Hoya M; Nagamatsu T; Fujii T; Schust DJ; Oda H; Akiba N; Iriyama T; Kawana K; Osuga Y; Fujii T
    Am J Reprod Immunol; 2018 Mar; 79(3):. PubMed ID: 29363849
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bacillus anthracis edema toxin acts as an adjuvant for mucosal immune responses to nasally administered vaccine antigens.
    Duverger A; Jackson RJ; van Ginkel FW; Fischer R; Tafaro A; Leppla SH; Fujihashi K; Kiyono H; McGhee JR; Boyaka PN
    J Immunol; 2006 Feb; 176(3):1776-83. PubMed ID: 16424208
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of nasal immunization with protective antigen of Bacillus anthracis on protective immune response against anthrax toxin.
    Gaur R; Gupta PK; Banerjea AC; Singh Y
    Vaccine; 2002 Jun; 20(21-22):2836-9. PubMed ID: 12034111
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Negative modulation of invariant natural killer T cell responses to glycolipid antigens by p38 MAP kinase.
    Stuart JK; Bisch SP; Leon-Ponte M; Hayatsu J; Mazzuca DM; Maleki Vareki S; Haeryfar SM
    Int Immunopharmacol; 2010 Sep; 10(9):1068-76. PubMed ID: 20584631
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The paradoxical effects of lead in interferon-gamma knockout BALB/c mice.
    Gao D; Kasten-Jolly J; Lawrence DA
    Toxicol Sci; 2006 Feb; 89(2):444-53. PubMed ID: 16280381
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.